Targeting neutrophils for cancer therapy

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Neutrophils are abundant immune cells in the tumor microenvironment.
• Their presence is linked to poor patient outcomes in various cancers.
• Therapeutic strategies targeting neutrophils are emerging but limited.

Purpose of the Study:

• To review the diverse neutrophil subtypes in cancer.
• To explore their mechanisms in tumor progression and immune evasion.
• To identify potential therapeutic targets for cancer treatment.

Main Methods:

• Literature review of neutrophil roles in cancer.
• Analysis of molecular pathways and effector functions.
• Examination of emerging clinical trials targeting neutrophils.

Main Results:

• Identification of distinct neutrophil subtypes with varying roles, including anti-tumor activity.
• Understanding of how neutrophils polarize towards tumor-suppressive phenotypes.
• Insights into molecular mechanisms by which neutrophils influence cancer progression.

Conclusions:

• Targeting neutrophils offers a promising therapeutic avenue for cancer.
• Further research into neutrophil heterogeneity is crucial for effective treatment strategies.
• Modulating neutrophil lineages may improve patient outcomes in cancer therapy.